
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Dinosaur collagen used to create one-of-a-kind handbag - 2
Grasping the Elements of Medical caretaker Pay rates: Factors That Shape Your Pay - 3
Reports: Nepal's former PM arrested over deadly protest crackdown - 4
‘Ukrainian housewives’ and Skyranger delays – German defense poster child Rheinmetall is in hot water - 5
Vote In favor of Your #1 Electric Vehicles
Josh Duhamel's secret to the good life at 53? Wolverine peptides, ditching Hollywood and having another baby.
Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list
New nesting beach for birds at RSPB reserve
Best Internet based Course for Learning Another Dialect: Which Stage Do You Like?
6 Top Computer game Control center
Mexico says a third of 130,000 missing people might be alive, fueling criticisms by families
Vote In favor of Your Favored Web-based Book Retailor
AI is providing emotional support for employees – but is it a valuable tool or privacy threat?
Sustaining Public activity and Connections: Key Methodologies













